SMTI NASDAQ
Sanara MedTech Inc.
1W: -0.9%
1M: -6.4%
3M: +8.6%
YTD: +42.2%
1Y: +5.7%
3Y: +17.4%
5Y: -5.9%
$32.84
-0.18 (-0.55%)
Weekly Expected Move ±2.8%
$31
$32
$33
$34
$35
Credit Risk of going bust: higher than 55% of companies Debt: 13.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.59 (down 98%), Sanara MedTech Inc. would be worth roughly what it owes.
Total debt $48.5M against a stock market value of $301.7M.
Distance to default 4.65 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.2M (short-term plus half of long-term), stock volatility 58.4%; Altman Z 3.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.59 (down 98%), Sanara MedTech Inc. would be worth roughly what it owes.
Total debt $48.5M against a stock market value of $301.7M.
Distance to default 4.65 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.2M (short-term plus half of long-term), stock volatility 58.4%; Altman Z 3.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-07-19
Earliest Filing
2025-04-04
Latest Filing
partner: 7
acquirer: 2
target: 2
investor: 1
Counterparties (Filed by SMTI)
12 relationshipsCompanies named in SMTI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| TISSUE HEALTH PLUS, LLC | — | acquirer | Purchaser acquiring 100% equity of CarePics | 2025-04-04 | View |
| SANARA MEDTECH INC. | SMTI | partner | Direct parent of the Purchaser | 2025-04-04 | View |
| CAREPICS, LLC | — | target | Target company whose equity is being acquired | 2025-04-04 | View |
| Biomimetic Innovations Ltd | — | partner | Exclusive license and distribution partner receiving minority equity investment | 2025-01-22 | View |
| PBC Biomed | — | partner | Affiliate of Biomimetic Innovations providing commercial support and manufacturing | 2025-01-22 | View |
| CelgenTek Innovations | — | partner | Former affiliate of PBC Biomed, acquired by Zimmer Biomet in 2016 | 2025-01-22 | View |
| Zimmer Biomet | ZBH | partner | Acquirer of CelgenTek Innovations | 2025-01-22 | View |
| Mochida Pharmaceuticals Ltd | — | partner | Partner company with PBC Biomed for ReFeel nerve regeneration solution | 2025-01-22 | View |
| Cantor Fitzgerald & Co. | — | partner | Sales agent for the controlled equity offering of common stock. | 2023-02-24 | View |
| Scendia Biologics, LLC | — | target | Acquired by Sanara MedTech Inc. | 2022-07-15 | View |
| Furneaux Capital Holdco, LLC | — | investor | Holder of the Common Stock Warrant issued by Sanara MedTech Inc. | 2022-04-08 | View |
| Rochal Industries, LLC | — | acquirer | Seller of assets including intellectual property, furniture, and equipment to Sanara MedTech Inc. | 2021-07-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-16 | Other Events | View | |
| 2026-10-01 | Shareholder Vote; Other Events | View | |
| 2026-08-11 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-07-29 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-06-09 | Shareholder Vote | View | |
| 2026-06-04 | Termination of Agreement | View | |
| 2026-05-11 | Earnings Release; Exhibits | View | |
| 2026-03-24 | Earnings Release; Exhibits | View | |
| 2026-03-02 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-26 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-02 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-28 | Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Financial Statements | View | |
| 2025-05-23 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-22 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR